We identified a EP300-ZNF384 fusion protein binding sequence at the IL3RA promoter and proved the fusion of EP300 with ZNF384 increased the transaction activity at the IL3RA promoter, leading to a much higher expression of IL3Rα on B-ALL cell membrane. The gene discussed is EP300; the disease is acute lymphoblastic leukemia.